# Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting ("DINOSAur")

> **NCT05692466** · — · UNKNOWN · sponsor: **Glendale Adventist Medical Center d/b/a Adventist Health Glendale** · enrollment: 572 (estimated)

## Conditions studied

- Stage III Solid Tumors
- Stage IV Solid Tumors

## Interventions

- **DIAGNOSTIC_TEST:** Comprehensive molecular panel test
- **OTHER:** EORTC QLQ-30

## Key facts

- **NCT ID:** NCT05692466
- **Lead sponsor:** Glendale Adventist Medical Center d/b/a Adventist Health Glendale
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 572 (ESTIMATED)
- **Last updated:** 2023-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05692466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05692466, "Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting ("DINOSAur")". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05692466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*